Physician Photo

Sherri-Ann M. Burnett-Bowie, MD, MPH

Director, Multicultural Affairs

  • Phone: 617-726-8720
Departments
Endocrinology
Department of Medicine

Specialties

  • Cancer Center
  • Endocrine Tumors
Clinical Interests
Osteoporosis
Hypercalcemia
Hypocalcemia
Hypophosphatemia
Vitamin D deficiency
Adrenal nodules
Adrenal insufficiency
Hyperthyroidism
Hypothyroidism
Kidney stones
Locations
Boston: Massachusetts General Hospital
Medical Education
MPH, Harvard School of Public Health
MD, University of Pittsburgh School of Medicine
Residency, Massachusetts General Hospital
Fellowship, Massachusetts General Hospital
Board Certifications
Endocrinology, Diabetes & Metabolism, American Board of Internal Medicine
Gender
Female
Patient Gateway
Yes, learn more
Patient Age Group
Adult
Accepting New Patients
Yes

Biography

Sherri-Ann M. Burnett-Bowie MD, MPH is an Assistant Professor of Medicine at Harvard Medical School and a clinical investigator in the Massachusetts General Hospital (MGH) Endocrine Unit, where her research focuses on defining the physiology of a new mineral metabolism hormone, FGF23; skeletal and non-skeletal effects of vitamin D; and clinical trials of treatments for osteoporosis.  She cares for patients seen at the MGH Endocrine Associates and the MGH Bone Density Center.  Dr. Burnett-Bowie is an Associate Director of the MGH Multicultural Affairs Office and the Director for Multicultural Affairs for the Department of Medicine at MGH.  Teaching and increasing diversity and inclusivity are central to her mission.

ResearchHer research is focused on defining the physiology of a new phosphate-regulating hormone, FGF23, skeletal and non-skeletal consequences of vitamin D deficiency, and clinical trials of treatments for osteoporosis.

Publications

  1. Burnett, SM, S Gunawardene, FR Bringhurst et al.  Regulation of c-terminal and intact FGF23 by dietary phosphate in men and women.  JBMR 2006.
  2. Burnett-Bowie, SM , BZ Leder, MP Henao et al. Randomized trial assessing the effects of ergocalciferol administration on circulating FGF23. CJASN 2012.
  3. Mitchell, DM, MP Henao, JS Finkelstein, SM Burnett-Bowie. Prevalence & predictors of vitamin D deficiency in healthy adults. JCEM 2012.
  4. Tsai, JN, Uihlein, AV, H Lee et al. Teriparatide & denosumab, alone or combined, in women with postmenopausal osteoporosis: the DATA study randomised trial. Lancet 2013
  5. Finkelstein , JS, H. Lee, SM Burnett-Bowie et al. Gonadal steroids & body composition, strength, and sexual function in men. NEJM 2013

In General awards and recognitions: May 4, 2012

In General awards and recognitions: May 4, 2012

Endocrine Associates
15 Parkman Street
Boston, MA 02114-3117

Phone: 617-726-8720
Fax: 617-724-2718